Publication Information

{'id': 'https://openalex.org/W2341567294', 'doi': 'https://doi.org/10.1056/jw200609070000001', 'title': 'Serious Infections with Anti-TNF Drugs for RA', 'display_name': 'Serious Infections with Anti-TNF Drugs for RA', 'publication_year': 2006, 'publication_date': '2006-01-01', 'ids': {'openalex': 'https://openalex.org/W2341567294', 'doi': 'https://doi.org/10.1056/jw200609070000001', 'mag': '2341567294'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://www.jwatch.org/jw200609070000001/2006/09/07/serious-infections-with-anti-tnf-drugs-ra', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764501393', 'display_name': 'Journal watch', 'issn_l': '0896-7210', 'issn': ['0896-7210'], 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/P4310320239', 'host_organization_name': 'Massachusetts Medical Society', 'host_organization_lineage': ['https://openalex.org/P4310320239'], 'host_organization_lineage_names': ['Massachusetts Medical Society'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': [], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5112048102', 'display_name': 'Allan S. Brett', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': True, 'raw_author_name': 'Allan S. Brett', 'raw_affiliation_strings': [], 'affiliations': []}], 'institution_assertions': [], 'countries_distinct_count': 0, 'institutions_distinct_count': 0, 'corresponding_author_ids': ['https://openalex.org/A5112048102'], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 61}, 'biblio': {'volume': '2006', 'issue': None, 'first_page': None, 'last_page': None}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10200', 'display_name': 'Rheumatoid Arthritis Research and Therapies', 'score': 0.9995, 'subfield': {'id': 'https://openalex.org/subfields/2745', 'display_name': 'Rheumatology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10200', 'display_name': 'Rheumatoid Arthritis Research and Therapies', 'score': 0.9995, 'subfield': {'id': 'https://openalex.org/subfields/2745', 'display_name': 'Rheumatology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10308', 'display_name': 'Systemic Lupus Erythematosus Research', 'score': 0.996, 'subfield': {'id': 'https://openalex.org/subfields/2745', 'display_name': 'Rheumatology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11725', 'display_name': 'Immunodeficiency and Autoimmune Disorders', 'score': 0.9958, 'subfield': {'id': 'https://openalex.org/subfields/2403', 'display_name': 'Immunology'}, 'field': {'id': 'https://openalex.org/fields/24', 'display_name': 'Immunology and Microbiology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [], 'concepts': [{'id': 'https://openalex.org/C2777226972', 'wikidata': 'https://www.wikidata.org/wiki/Q415343', 'display_name': 'Etanercept', 'level': 3, 'score': 0.9474851}, {'id': 'https://openalex.org/C2780132546', 'wikidata': 'https://www.wikidata.org/wiki/Q348260', 'display_name': 'Adalimumab', 'level': 3, 'score': 0.92716706}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.9257442}, {'id': 'https://openalex.org/C2777138892', 'wikidata': 'https://www.wikidata.org/wiki/Q415264', 'display_name': 'Infliximab', 'level': 3, 'score': 0.91916615}, {'id': 'https://openalex.org/C2777575956', 'wikidata': 'https://www.wikidata.org/wiki/Q187255', 'display_name': 'Rheumatoid arthritis', 'level': 2, 'score': 0.86490214}, {'id': 'https://openalex.org/C17991360', 'wikidata': 'https://www.wikidata.org/wiki/Q21173843', 'display_name': 'Tumor necrosis factor alpha', 'level': 2, 'score': 0.7264453}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.5538995}, {'id': 'https://openalex.org/C3020084786', 'wikidata': 'https://www.wikidata.org/wiki/Q21173843', 'display_name': 'Tumor necrosis factor α', 'level': 3, 'score': 0.4695388}, {'id': 'https://openalex.org/C203014093', 'wikidata': 'https://www.wikidata.org/wiki/Q101929', 'display_name': 'Immunology', 'level': 1, 'score': 0.3488282}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://www.jwatch.org/jw200609070000001/2006/09/07/serious-infections-with-anti-tnf-drugs-ra', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764501393', 'display_name': 'Journal watch', 'issn_l': '0896-7210', 'issn': ['0896-7210'], 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/P4310320239', 'host_organization_name': 'Massachusetts Medical Society', 'host_organization_lineage': ['https://openalex.org/P4310320239'], 'host_organization_lineage_names': ['Massachusetts Medical Society'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.88, 'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W994319339', 'https://openalex.org/W84345071', 'https://openalex.org/W3027547487', 'https://openalex.org/W2755836100', 'https://openalex.org/W2745607337', 'https://openalex.org/W2415880475', 'https://openalex.org/W2164421909', 'https://openalex.org/W2118096602', 'https://openalex.org/W2081148269', 'https://openalex.org/W2079272488', 'https://openalex.org/W2059944081', 'https://openalex.org/W2052067610', 'https://openalex.org/W2021115373', 'https://openalex.org/W2004670542', 'https://openalex.org/W1970059200', 'https://openalex.org/W1969452774', 'https://openalex.org/W1966524332', 'https://openalex.org/W1901284258', 'https://openalex.org/W1823274426', 'https://openalex.org/W1580176045'], 'abstract_inverted_index': {'Patients': [0], 'who': [1], 'receive': [2], 'anti–tumor': [3], 'necrosis': [4], 'factor': [5], '(TNF)': [6], 'drugs': [7, 38], 'for': [8, 15], 'rheumatoid': [9], 'arthritis': [10], '(RA)': [11], 'are': [12], 'at': [13], 'risk': [14], 'serious': [16, 31], 'infections.': [17], 'U.K.': [18], 'researchers': [19], 'used': [20], 'a': [21], 'national': [22], 'registry': [23], 'of': [24, 30], 'RA': [25], 'patients': [26, 35, 48], 'to': [27], 'compare': [28], 'rates': [29], 'infections': [32], 'in': [33], '7664': [34], 'receiving': [36, 49], 'anti-TNF': [37], '(etanercept': [39], '[Enbrel],': [40], 'infliximab': [41], '[Remicade],': [42], 'and': [43, 46], 'adalimumab': [44], '[Humira])': [45], '1354': [47], '…': [50]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2341567294', 'counts_by_year': [], 'updated_date': '2024-12-08T18:09:43.480058', 'created_date': '2016-06-24'}